Theophylline
NDC 27241-273, Theophylline, tablet, extended release, from Ajanta Pharma USA Inc..
- Product NDC
- 27241-273
- Status
- Listed
- Labeler
- Ajanta Pharma USA Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218401
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/27241-273 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- THEOPHYLLINE ANHYDROUS450 mg/1
Pharmacologic classes
Methylxanthine [EPC]; Xanthines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 27241-273-01 | 27241027301 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-273-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7a422c32-bbdf-4297-84f4-9c438c904b0c
Use it
Look up 27241-273 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/27241-273 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 27241-273. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.